International Nonproprietary Names Programme and Classification of Medical Products

International Nonproprietary Names (INN)

International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name.

Mandate

WHO has a constitutional mandate to "develop, establish and promote international standards with respect to biological, pharmaceutical and similar products".

The World Health Organization collaborates closely with INN experts and national nomenclature committees to select a single name of worldwide acceptability for each active substance that is to be marketed as a pharmaceutical. To avoid confusion, which could jeopardize the safety of patients, trade-marks should neither be derived from INNs nor contain common stems used in INNs. The selection and publication of INNs falls under the responsibility of the EMP/RHT/TSN team of the INN Programme. 

Guidance on INN

Nonproprietary names are intended for use in pharmacopoeias, labelling, product information, advertising and other promotional material, drug regulation and scientific literature, and as a basis for product names, e.g. for generics. Their use is normally required by national or, as in the case of the European Community, by international legislation. As a result of ongoing collaboration, national names such as British Approved Names (BAN), Dénominations Communes Françaises (DCF), Japanese Adopted Names (JAN) and United States Adopted Names (USAN) are nowadays, with rare exceptions, identical to the INN.

Read More

Dr R. Balocco Mattavelli

World Health Organization
International Nonproprietary Names
(MHP/HPS/INN)
20 Avenue Appia
1211, Geneva 27
Switzerland
Tel: +41 22 791 1249
Fax: +41 22 791 4730

innprogramme@who.int

Events

Related Health topics

Teams